1 Min Read
May 3 (Reuters) - Odonate Therapeutics Inc:
* ODONATE THERAPEUTICS ANNOUNCES FINANCIAL RESULTS FOR THE THREE MONTHS ENDED MARCH 31, 2018
* QUARTERLY LOSS PER SHARE $0.69 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.